article · Journal of Microscopy and Ultrastructure
Abstract Background: Vitamin D, acting via the vitamin D receptor (VDR), has antitumor effects through inhibition of proliferation and angiogenesis. Some previous studies showed an inverse correlation between VDR expression and the progression of cutaneous melanoma, whereas other studies did not confirm this correlation, suggesting a probable ethnic/geographic effect. We aimed to evaluate the expression pattern of VDR in cases of cutaneous melanoma in a Middle Eastern country, Egypt. Materials and Methods: A total of 42 paraffin blocks and slides from 42 patients were retrieved from the pathology archives of our institution and immunohistochemically stained against VDR. The density and pattern of VDR immunostaining in positively stained cases were analyzed and compared with various demographic, clinical, and histological parameters of Egyptian patients who underwent surgical excision for cutaneous melanoma between 2017 and 2022. Results: A total of 37 cases (88.1%) expressed VDR, showing no significant correlation with the tumor site, size, metastasis, or invasion. In contrast, a statistically significant difference was observed between nuclear and cytoplasmic VDR expression. Nuclear expression was associated with unfavorable tumor characteristics, including increased Breslow thickness, Clark level, and vascular invasion. Conclusion: VDR expression can serve as a prognostic marker in the histopathological evaluation of cutaneous melanoma; the utility of nuclear versus cytoplasmic VDR expression should be further investigated in future research incorporating genetic analysis. Our findings, in contrast to several previous studies but in agreement with a few, suggest an association between nuclear staining and tumor progression.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/jmau.jmau_83_24
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.